The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs

Author(s): E. Niederberger, C. V. Moser, K. L. Kynast, G. Geisslinger.

Journal Name: Current Molecular Medicine

Volume 13 , Issue 7 , 2013

Become EABM
Become Reviewer

Abstract:

IκB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1) are two non-canonical IKKs which are involved in interferon regulatory factor (IRF) as well as nuclear factor kappaB (NF-κB) signaling cascades. Both kinases have already been linked to the pathophysiology of several diseases and therefore been suggested as potential promising targets for the development of therapeutic drugs. In this review, we summarize the roles of IKKε and TBK1 in different diseases and outline therapeutic options for modulation of these kinases.

Keywords: Cancer, IKKε, inflammation, interferon regulatory factor, NF-κB, TBK1.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 13
ISSUE: 7
Year: 2013
Page: [1089 - 1097]
Pages: 9
DOI: 10.2174/1566524011313070004
Price: $58

Article Metrics

PDF: 43